ROYAL BANK OF CANADA - GRACELL BIOTECHNOLOGIES INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of GRACELL BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$0300.0%0.00%
Q2 2023$030
-73.9%
0.00%
Q1 2023$0115
+155.6%
0.00%
Q4 2022$045
-57.9%
0.00%
Q3 2022$0
-100.0%
107
-93.3%
0.00%
Q2 2022$9,0001,6000.00%
Other shareholders
GRACELL BIOTECHNOLOGIES INC shareholders Q4 2023
NameSharesValueWeighting ↓
Vivo Capital, LLC 10,881,144$31,337,6953.43%
Sio Capital Management, LLC 2,081,216$5,993,9021.86%
Pivotal bioVenture Partners Investment Advisor LLC 1,375,000$3,960,0001.58%
TCG Crossover Management, LLC 3,038,889$8,752,0001.29%
Logos Global Management LP 2,525,000$7,272,0000.97%
SPHERA FUNDS MANAGEMENT LTD. 1,531,497$4,410,7110.80%
Orbimed Advisors 9,308,726$26,809,1310.57%
GREAT POINT PARTNERS LLC 579,667$1,669,4410.30%
Temasek Holdings (Private) Ltd 9,901,940$28,517,5870.17%
TANG CAPITAL MANAGEMENT LLC 159,087$458,1710.06%
View complete list of GRACELL BIOTECHNOLOGIES INC shareholders